| MEDIGENE AG 31.12.2049 | 0.889 |
| Date/Time | 09/02 / 22:57 |
| Chg. / Chg.(%) | - / |
| Bid | 0.889 |
| Ask | 0.921 |
| Open | 0.859 |
| Previous Close | 0.859 |
| High | 0.901 |
| Low | 0.859 |
| Volume [EUR] | - |
| Volume [Units] | |
| Price fixings | 635 |
| ISIN | DE0005020903 |
| Security | 502090 |
| Exchange | Lang & Schwarz |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Hannover | 3.632 | 75 | |
| Lang & Schwa.. | 0.889 | ||
| Hamburg | 3.440 |
News
- Medigene enters Phase I clinical development with its TCR-T immunotherapy MDG1021 in hematological cancers
06/23/2020 / 22:46 - GlobeNewswire - PTA-News: Medigene AG: Medigene enters Phase I clinical development with its TCR-T immunotherapy MDG1021 in hematological cancers
06/23/2020 / 22:00 - pressetext - Medigene’s PD1-41BB Switch Receptor Enhances TCR-T Cell Activity Towards Solid Tumors
06/22/2020 / 15:00 - GlobeNewswire - PTA-News: Medigene AG: Medigene's PD1-41BB switch receptor enhances TCR-T cell activity towards solid tumors<BR/>Poster presentation at the AACR Virtual Annual Meeting II, 22 - 24 June 2020
06/22/2020 / 15:00 - pressetext - iTeos Therapeutics Strengthens Leadership Team
06/09/2020 / 13:00 - GlobeNewswire
Real-time